Risperdal (risperidone) originated in the early 1990's as a means of treating people who were suffering with varying forms of behavioral problems, including schizophrenia and bipolar disorders.
The drug was developed by Janssen-Cilag, a subsidiary medical company of Johnson & Johnson; although today is sold under different generic names after their patent expired in the year 2003. While this drug was successfully helping the patient’s illnesses and then many male patients were found to suffer with varying clinical consequences as a result of the prescription.
Like other atypical antipsychotics, Risperdal drug targets the serotonin and dopamine receptors in the brain. This drug has been linked to a number of serious side-effects, including Risperdal gynecomastia, diabetes, and other movement disorders.
Since its approval, a number of studies have pointed to a link between the use of Risperdal and male breast development. For example, in 2006, a study published in the Journal of Clinical Psychopharmacology reported that some children who took Risperdal had developed high levels of the hormone prolactin, which is associated with breast development and lactation in new mothers. To get more details on Risperdal Gynecomastia Lawsuits, one can simply browse http://www.risperdalgynecomastialawsuitcenter.com/risperdal-male-breasts-lawsuit.asp.
A second study published in 2009 in the Journal of Child and Adolescent Psychopharmacology reported that the prolactin levels seen in Risperdal patients could persist for up to two years.